A total of 259 Endometrial Cancer, Ovarian Cancer and Cervical Cancer patients were included in this study, with their baseline characteristics, including age, type of cancer, TP53 mutations, BMI, Lymph node metastasis, tumor grade, as shown in Table 1. This evidence concerns the gene TP53 and neoplasm.